Investors in Altria Group are currently presented with a compelling yet precarious proposition. The tobacco giant is deploying substantial shareholder returns, featuring a towering dividend yield and fresh stock buybacks, to maintain its appeal. However, this financial generosity masks a fundamental operational decline, where rising prices are accelerating customer attrition. The central question for the market is whether the attractive income stream justifies the long-term risk of an eroding core business.
Shareholder Returns Provide a Cushion
In response to its structural challenges, Altria’s management is leaning heavily on capital returns to shareholders. This strategy aims to provide direct value and support per-share metrics.
* Dividend Payout: Following an increase in August, the annual dividend now stands at $4.24 per share. At current levels, this translates to a yield of approximately 7.3%.
* Buyback Program: A newly authorized $2 billion share repurchase program offers additional support for the equity.
While these mechanisms help artificially stabilize earnings per share (EPS), they do little to address the lack of underlying organic growth. The share price has shown limited dynamism, recently trading at 50.05 euros and remaining in negative territory for the year-to-date period with a decline of 2.21%.
The Fundamental Strain: Pricing Power vs. Volume Collapse
The company’s third-quarter results laid bare a critical tension. Altria successfully expanded the adjusted operating income margin for its smokeable products segment to a record 64.4%. This achievement, however, came at a significant cost.
Should investors sell immediately? Or is it worth buying Altria?
Total company revenue declined by 3.0% to $5.25 billion, missing market expectations. The most alarming data point was the dramatic 9% plunge in domestic cigarette shipment volumes. That EPS of $1.45 still managed to slightly exceed forecasts is attributable almost exclusively to aggressive price increases. This “price realization” strategy is increasingly viewed as a double-edged sword, potentially hastening the exodus of smokers from its flagship brands.
Divergent Views from Wall Street
Management has narrowed its full-year 2025 adjusted EPS guidance to a range of $5.37 to $5.45, signaling expectations for only modest growth. This outlook has led to a split among market analysts.
Goldman Sachs analysts emphasize the company’s persistent pricing power and see potential for significantly higher share prices. In contrast, experts at Jefferies warn that the unsustainable volume losses present a major headwind, identifying downside risk with a price target as low as $47. Ultimately, investors are acquiring a stake in a classic “cash cow” business, but one whose pasture is visibly and steadily shrinking.
Ad
Altria Stock: Buy or Sell?! New Altria Analysis from December 10 delivers the answer:
The latest Altria figures speak for themselves: Urgent action needed for Altria investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 10.
Altria: Buy or sell? Read more here...
